Ornidale N Tablet contains Ornidazole 500 mg and Norfloxacin 400 mg, a dual-action antimicrobial combination specifically designed for comprehensive management of gastrointestinal infections. Ornidazole targets anaerobic bacteria and protozoa, while Norfloxacin provides broad-spectrum antibacterial activity, ensuring effective eradication of intestinal pathogens.
Clinically, Ornidale N Tablet is indicated for acute diarrhea, dysentery, amoebiasis, gastroenteritis, and other mixed bacterial and protozoal intestinal infections. The combination ensures rapid relief of gastrointestinal symptoms, including abdominal cramps, loose stools, and discomfort, while addressing both bacterial and protozoal causes simultaneously.
The tablet is formulated to provide consistent bioavailability, precise dosing, and reliable therapeutic outcomes, making it suitable for hospitals, gastroenterology clinics, general practitioners, and specialty pharmacies. Its convenient oral dosage enhances patient compliance and adherence to prescribed treatment.
Regular administration under medical supervision helps in preventing recurrence, minimizing complications, and restoring gut health. The synergistic action of Ornidazole and Norfloxacin makes Ornidale N Tablet a clinically trusted, safe, and effective solution for managing complex gastrointestinal infections requiring dual antimicrobial therapy.